Efficacy and safety of novel biologics in the treatment of lupus nephritis based on registered clinical trials: a systematic review and network meta-analysis
This study protocol has been registered with PROSPERO, with a registration number of CRD42021262498.
Source: Clinical and Experimental Medicine - Category: Research Source Type: research
More News: Abatacept | Clinical Trials | Databases & Libraries | Lupus | Nephritis | Orencia | Research | Rituxan | Science | Statistics | Study | Urology & Nephrology